ATP-dependent MurE ligase in Mycobacterium tuberculosis: Biochemical and structural characterisation

Tuberculosis

Volumn 90, Issue 1, 2010, Pages 16-24

  Basavannacharya, Chandrakala ^a   Robertson, Giles ^a   Munshi, Tulika ^a   Keep, Nicholas H ^a   Bhakta, Sanjib ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

ATP dependent ligase; Cell wall peptidoglycan biosynthesis; Enzyme kinetics; Protein structure; Tuberculosis

Indexed keywords

ADENOSINE TRIPHOSPHATE DEPENDENT PROTEINASE; DIAMINOPIMELIC ACID; PEPTIDOGLYCAN; UDP MURNAC TRIPEPTIDE LIGASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BIOCHEMISTRY; CRYSTAL STRUCTURE; ENZYME KINETICS; ENZYME SYNTHESIS; GENE OVEREXPRESSION; GENETIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; MASS SPECTROMETRY; MOLECULAR CLONING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN STRUCTURE;

ADENOSINE TRIPHOSPHATE; BACTERIAL PROTEINS; CELL WALL; CLONING, MOLECULAR; CRYSTALLOGRAPHY, X-RAY; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PEPTIDE SYNTHASES; PEPTIDOGLYCAN; TUBERCULOSIS; UP-REGULATION;

EID: 75149131973     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2009.10.007     Document Type: Article

References (59)

1. Mandavilli A. Trials and tribulations. Nat Med 13 (2007) 272-273
2. Mandavilli A. Virtually incurable TB warns of impending disaster. Nat Med 13 (2007) 271
3. Reichman L.B. Tuberculosis drug resistance comes full circle. Lancet 371 (2008) 1052-1053
4. Brennan P.J. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb) 83 (2003) 91-97
5. Gao L.Y., Laval F., Lawson E.H., Groger R.K., Woodruff A., Morisaki J.H., et al. Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy. Mol Microbiol 49 (2003) 1547-1563
6. Bhatt A., Fujiwara N., Bhatt K., Gurcha S.S., Kremer L., Chen B., et al. Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice. Proc Natl Acad Sci U S A 104 (2007) 5157-5162
7. Vollmer W., Blanot D., and de Pedro M.A. Peptidoglycan structure and architecture. FEMS Microbiol Rev 32 (2008) 149-167
8. Barreteau H., Kovac A., Boniface A., Sova M., Gobec S., and Blanot D. Cytoplasmic steps of peptidoglycan biosynthesis. FEMS Microbiol Rev 32 (2008) 168-207
9. van Heijenoort J. Recent advances in the formation of the bacterial peptidoglycan monomer unit. Nat Prod Rep 18 (2001) 503-519
10. De Smet K.A., Kempsell K.E., Gallagher A., Duncan K., and Young D.B. Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis. Microbiology (Reading, England) 145 Pt 11 (1999) 3177-3184
11. Mahapatra S., Crick D.C., and Brennan P.J. Comparison of the UDP-N-acetylmuramate:l-alanine ligase enzymes from Mycobacterium tuberculosis and. Mycobacterium leprae. J Bacteriol 182 (2000) 6827-6830
12. Mahapatra S., Scherman H., Brennan P.J., and Crick D.C.N. Glycolylation of the nucleotide precursors of peptidoglycan biosynthesis of Mycobacterium spp. is altered by drug treatment. J Bacteriol 187 (2005) 2341-2347
13. Wietzerbin J., Das B.C., Petit J.F., Lederer E., Leyh-Bouille M., and Ghuysen J.M. Occurrence of d-alanyl-(d)-meso-diaminopimelic acid and meso-diaminopimelyl-meso-diaminopimelic acid interpeptide linkages in the peptidoglycan of Mycobacteria. Biochemistry 13 (1974) 3471-3476
14. Kotani S., Yanagida I., Kato K., and Matsuda T. Studies on peptides, glycopeptides and antigenic polysaccharide-glycopeptide complexes isolated from an L-11 enzyme lysate of the cell walls of Mycobacterium tuberculosis strain H37Rv. Biken journal 13 (1970) 249-275
15. Mahapatra S., Yagi T., Belisle J.T., Espinosa B.J., Hill P.J., McNeil M.R., et al. Mycobacterial lipid II is composed of a complex mixture of modified muramyl and peptide moieties linked to decaprenyl phosphate. J Bacteriol 187 (2005) 2747-2757
16. Vaganay S., Tanner M.E., van Heijenoort J., and Blanot D. Study of the reaction mechanism of the d-glutamic acid-adding enzyme from Escherichia coli. Microb Drug Resist 2 (1996) 51-54
17. Smith C.A. Structure, function and dynamics in the Mur family of bacterial cell wall ligases. J Mol Biol 362 (2006) 640-655
18. Gordon E., Flouret B., Chantalat L., van Heijenoort J., Mengin-Lecreulx D., and Dideberg O. Crystal structure of UDP-N-acetylmuramoyl-l-alanyl-d-glutamate: meso-diaminopimelate ligase from Escherichia coli. J Biol Chem 276 (2001) 10999-11006
19. Mengin-Lecreulx D., Falla T., Blanot D., van Heijenoort J., Adams D.J., and Chopra I. Expression of the Staphylococcus aureus UDP-N-acetylmuramoyl-l-alanyl-d-glutamate:l-lysine ligase in Escherichia coli and effects on peptidoglycan biosynthesis and cell growth. J Bacteriol 181 (1999) 5909-5914
20. Jana M., Luong T.T., Komatsuzawa H., Shigeta M., and Lee C.Y. A method for demonstrating gene essentiality in Staphylococcus aureus. Plasmid 44 (2000) 100-104
21. Sassetti C.M., Boyd D.H., and Rubin E.J. Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48 (2003) 77-84
22. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 (1998) 537-544
23. Tipper D.J., and Pratt I. Cell wall polymers of Bacillus sphaericus 9602. II. Synthesis of the first enzyme unique to cortex synthesis during sporulation. J Bacteriol 103 (1970) 305-317
24. Hu X., Fan W., Han B., Liu H., Zheng D., Li Q., et al. Complete genome sequence of the mosquitocidal bacterium Bacillus sphaericus C3-41 and comparison with those of closely related Bacillus species. J Bacteriol 190 (2008) 2892-2902
25. Leslie A.G.W. Recent changes to the MOSFLM package for processing film and image plate data. Jnt CCP4+ ESF-EAMCB Newslett Protein Crystallogr 26 (1992)
26. Evans P. Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr 62 (2006) 72-82
27. Keegan R.M., and Winn M.D. Automated search-model discovery and preparation for structure solution by molecular replacement. Acta Crystallogr D Biol Crystallogr 63 (2007) 447-457
28. Vagin A., and Teplyakov A. MOLREP: an automated program for molecular replacement. J Appl Crystallogr 30 (1997) 1022-1025
29. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53 (1997) 240-255
30. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60 (2004) 2126-2132
31. Winn M.D., Murshudov G.N., and Papiz M.Z. Macromolecular TLS refinement in REFMAC at moderate resolutions. Methods Enzymol 374 (2003) 300-321
32. Krissinel E., and Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol 372 (2007) 774-797
33. Krissinel E., and Henrick K. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr 60 (2004) 2256-2268
34. Yan Y., Munshi S., Leiting B., Anderson M.S., Chrzas J., and Chen Z. Crystal structure of Escherichia coli UDPMurNAc-tripeptide d-alanyl-d-alanine-adding enzyme (MurF) at 2.3 A resolution. J Mol Biol 304 (2000) 435-445
35. Bertrand J.A., Auger G., Martin L., Fanchon E., Blanot D., Le Beller D., et al. Determination of the MurD mechanism through crystallographic analysis of enzyme complexes. J Mol Biol 289 (1999) 579-590
36. Raymond J.B., Mahapatra S., Crick D.C., and Pavelka Jr. M.S. Identification of the namH gene, encoding the hydroxylase responsible for the N-glycolylation of the mycobacterial peptidoglycan. J Biol Chem 280 (2005) 326-333
37. Azzolina B.A., Yuan X., Anderson M.S., and El-Sherbeini M. The cell wall and cell division gene cluster in the Mra operon of Pseudomonas aeruginosa: cloning, production, and purification of active enzymes. Protein Exp Purif 21 (2001) 393-400
38. Michaud C., Mengin-Lecreulx D., van Heijenoort J., and Blanot D. Over-production, purification and properties of the uridine-diphosphate-N-acetylmuramoyl-l-alanyl-d-glutamate: meso-2,6-diaminopimelate ligase from Escherichia coli. Eur J Biochem 194 (1990) 853-861
39. Thomas A.T., Renee M.C., and David L.P. Cloning, expression and characterization of the Streptococcus pyogenes murE gene encoding a UDP-MurNAc-l-alanyl-d-glutamate: l-lysine ligase. Enzyme and Microbial Technology 35 (2004) 300-308
40. Flouret B., Mengin-Lecreulx D., and van Heijenoort J. Reverse-phase high-pressure liquid chromatography of uridine diphosphate N-acetylmuramyl peptide precursors of bacterial cell wall peptidoglycan. Anal Biochem 114 (1981) 59-63
41. In: Labischinski H., and Maidhof H. (Eds). Bacterial cell wall vol. 27 (1994), Elsevier Science, Amsterdam 23-38
42. Ito E., and Strominger J.L. Enzymatic synthesis of the peptide in bacterial uridine nucleotides. VII. Comparative biochemistry. J Biol Chem 248 (1973) 3131-3136
43. Bhakta S., and Basu J. Overexpression, purification and biochemical characterization of a class A high-molecular-mass penicillin-binding protein (PBP), PBP1* and its soluble derivative from Mycobacterium tuberculosis. Biochem J 361 (2002) 635-639
44. Lavollay M., Arthur M., Fourgeaud M., Dubost L., Marie A., Veziris N., et al. The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by l, d-transpeptidation. J Bacteriol 190 (2008) 4360-4366
45. Mengin-Lecreulx D., Blanot D., and van Heijenoort J. Replacement of diaminopimelic acid by cystathionine or lanthionine in the peptidoglycan of Escherichia coli. J Bacteriol 176 (1994) 4321-4327
46. Boniface A., Bouhss A., Mengin-Lecreulx D., and Blanot D. The MurE synthetase from Thermotoga maritima is endowed with an unusual d-lysine adding activity. J Biol Chem 281 (2006) 15680-15686
47. Nathenson S.G., Strominger J.L., and Ito E. Enzymatic synthesis of the peptide in bacterial uridine nucleotides. IV. Purification and properties of d-glutamic acid-adding enzyme. J Biol Chem 239 (1964) 1773-1776
48. Ito E., and Strominger J.L. Enzymatic synthesis of the peptide in bacterial uridine nucleotides. III. Purification and properties of l-lysin-adding enzyme. J Biol Chem 239 (1964) 210-214
49. Anishetty S., Pulimi M., and Pennathur G. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis. Comput Biol Chem 29 (2005) 368-378
50. Silver L.L. Novel inhibitors of bacterial cell wall synthesis. Curr Opin Microbiol 6 (2003) 431-438
51. Bratkovic T., Lunder M., Urleb U., and Strukelj B. Peptide inhibitors of MurD and MurE, essential enzymes of bacterial cell wall biosynthesis. J Basic Microbiol 48 (2008) 202-206
52. Gegnas L.D., Waddell S.T., Chabin R.M., Reddy S., and Wong K.K. Inhibitors of the bacterial cell wall biosynthesis enzyme MurD. Bioorg Med Chem Lett 8 (1998) 1643-1648
53. Perdih A., Kovac A., Wolber G., Blanot D., Gobec S., and Solmajer T. Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach. Bioorg Med Chem Lett 19 (2009) 2668-2673
54. Strancar K., Boniface A., Blanot D., and Gobec S. Phosphinate inhibitors of UDP-N-acetylmuramoyl-l-alanyl-d-glutamate: l-lysine ligase (MurE). Arch Pharm (Weinheim) 340 (2007) 127-134
55. Tanner M.E., Vaganay S., van Heijenoort J., and Blanot D. Phosphinate inhibitors of the d-glutamic acid-adding enzyme of peptidoglycan biosynthesis. J Org Chem 61 (1996) 1756-1760
56. Tomasic T., Zidar N., Rupnik V., Kovac A., Blanot D., Gobec S., et al. Synthesis and biological evaluation of new glutamic acid-based inhibitors of MurD ligase. Bioorg Med Chem Lett 19 (2009) 153-157
57. Turk S., Kovac A., Boniface A., Bostock J.M., Chopra I., Blanot D., et al. Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening. Bioorg Med Chem 17 (2009) 1884-1889
58. Kahan F.M., Kahan J.S., Cassidy P.J., and Kropp H. The mechanism of action of fosfomycin (phosphonomycin). Ann N Y Acad Sci 235 (1974) 364-386
59. Projan S.J. New (and not so new) antibacterial targets - from where and when will the novel drugs come?. Curr Opin Pharmacol 2 (2002) 513-522